In a January 2024 update, the FDA stated that its preliminary evaluation has not found evidence that GLP-1 RAs cause suicidal thoughts or actions, based on available clinical trial data and adverse event reports (FDA Drug Safety Communication, 2024)
India First generics of semaglutide will launch in early 2026 after Novo Nordisks patent expires in January 2026
[1] [4] Lupus patients should be aware of symptoms such as right upper quadrant pain, fever, or jaundice, which require prompt medical attention
For example, metformin is one of Synjardys active ingredients, and it costs less than $10 with a SingleCare coupon
Copper is an essential cofactor for many biochemical processes, and binding it to GHK creates a peptide-copper model for laboratory study
Thus, nonparametric tests (Kruskal-Wallis, Mann-Whitney U, Wilcoxon signed rank tests) were used to compare continuous variables